SMARCA4, a well-known tumor suppressor gene [20] that can serve as prognostic indicators in non-small cell lung cancer [21] and breast cancer [22], was under-expressed in a small fraction of samples from the Shedden_2008 study [23], and the corresponding patients had worse survival outcome (Fig. 3c). This evidence concerns the gene SMARCA4 and breast cancer.